
SafeBeat
SafeBeat is a YC Summer 2021 (S21) company. Based in San Francisco, CA, USA. Team of 9.
About SafeBeat
Summary
SafeBeat builds an ML-powered ECG software platform that guides physicians through drug dosing decisions for patients with heart rhythm disorders, replacing in-clinic monitoring protocols that today block or slow access to antiarrhythmic medications. The platform integrates with existing FDA-cleared wearable cardiac monitors and surfaces patient-specific diagnostic data and treatment steps directly on a clinician's phone, removing the need for patients to visit a facility for mandatory ECG surveillance.
Go-to-market
Clinicians and health systems treating arrhythmia patients are the buyers; the product is accessed through the SafeBeat Rx platform, which pairs with third-party cardiac monitoring hardware already in use.
From the Y Combinator listing
Guiding cardiac therapeutics - all from your phone
38 million people suffer from heart rhythm disorders and are recommended to start medications that can save their lives, but require rigorous ECG monitoring to start and remain on these pills. SafeBeat Rx moves beyond diagnostics to guide these therapeutics, powered by our ML ECG software that integrates with existing FDA-cleared wearables to allow seamless physician approval of drug dosing, all from a mobile phone. We are a team of physicians, engineers, data scientists, and machine learning experts dedicated to using engineering to improve heart health.
Facts
- Healthcare / Healthcare -> Medical Devices
- San Francisco, CA, USA
- 9
- Active
- Early
Founders (1)
- Rachita Navara
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works